Verified Nov 2026
Other
·

Bresso, Lombardia
·
Since 1906
Zambon Company SpA is a family-owned Italian pharmaceutical and chemical manufacturer headquartered in Bresso, founded in 1906. With 2,800–2,900 employees and estimated revenue of €899 million (2023), the company operates across 87 countries. It develops treatments for rare and severe diseases including respiratory conditions, central nervous system disorders, and Parkinson's disease, and in 2026 received European Commission approval for Hopledo® to treat motor fluctuations in Parkinson's patients.
Zambon Company SpA at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Founded
1906
Headquarters
Bresso, Lombardia
Certifications
ISO 14001
Industries
Automotive
Electric Vehicles
Medical
Renewable Energy
Industrial Equipment
STABILITY SIGNALS
Established & active
120 years in operation (founded 1906).
Holds ISO 14001 certification(s) per public sources.
Overview
Zambon Company SpA is a family-owned Italian pharmaceutical and chemical manufacturer headquartered in Bresso, founded in 1906. With 2,800–2,900 employees and estimated revenue of €899 million (2023), the company operates across 87 countries. It develops treatments for rare and severe diseases including respiratory conditions, central nervous system disorders, and Parkinson's disease, and in 2026 received European Commission approval for Hopledo® to treat motor fluctuations in Parkinson's patients.
At a glance
Attribute | Detail |
|---|---|
Founded | 1906 |
Headquarters | Bresso, Lombardia |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
Certifications | ISO 14001 |
What Zambon Company SpA makes
Zambon manufactures active pharmaceutical ingredients and finished drug products focused on severe respiratory diseases, Central Nervous System disorders, women's health, pain management, and cough and cold treatments, and holds ISO 14001 certification.
Products and capabilities described on the company's own site include LED (source: zambon.com).
Certifications
Zambon Company SpA is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 14001 — zambon.com
Latest developments
2026-09-23 — Expanding our industrial capabilities for the future | Zach - Zambon Chemicals (linkedin.com)
2026-08-28 — Zambon announces European Commission approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations | Zambon (zambon.com)
2026-04-28 — Cultipharm and Zambon Announce Strategic Agreement for the Development of Advanced Nutraceutical Product Lines | Zambon (zambon.com)
2025-12-22 — Zambon Biotech announces first patient dosed in Phase 3b ADIP clinical study of IPX203 in Parkinson’s disease | Zambon (zambon.com)
2025-12-18 — We are pleased to announce the signing of a License Development Agreement with PARI, aimed at advancing a next-generation drug–device combination therapy for patients with non-Cystic Fibrosis Bronchiectasis. | Zambon (linkedin.com)
2025-12-07 — Zambon verso il miliardo di ricavi: «Qui etica e profitti vanno insieme» | Corriere.it (corriere.it)
Company details
The company operates manufacturing facilities in Italy, Switzerland, France, China, and Brazil, and is led by Elena Zambon, granddaughter of the founder. Zambon Company SpA was founded in 1906, has an estimated 1,000-5,000 employees, and is headquartered in Bresso, Lombardia. On the LightSource stability read it is rated "Established & active": 120 years in operation (founded 1906). Holds ISO 14001 certification(s) per public sources.
Frequently asked questions
What does Zambon Company SpA do?
Zambon Company SpA is a family-owned Italian pharmaceutical and chemical manufacturer headquartered in Bresso, founded in 1906. With 2,800–2,900 employees and estimated revenue of €899 million (2023), the company operates across 87 countries. It develops treatments for rare and severe diseases including respiratory conditions, central nervous system disorders, and Parkinson's disease, and in 2026 received European Commission approval for Hopledo® to treat motor fluctuations in Parkinson's patients.
Where is Zambon Company SpA headquartered?
Zambon Company SpA is headquartered in Bresso, Lombardia (10 Via Lillo del Duca, Bresso, Lombardia, 20091).
When was Zambon Company SpA founded?
Zambon Company SpA was founded in 1906.
How big is Zambon Company SpA?
Zambon Company SpA has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
What certifications does Zambon Company SpA hold?
Zambon Company SpA lists ISO 14001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
